Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Developmental Biology
|
September 9, 2018
Lung morphogenesis is orchestrated through Grainyhead-like 2 (Grhl2) transcriptional programs
Ariena Kersbergen, Sarah A Best, Sebastian Dworkin, et al.
Cancer Cell
|
January 15, 2016
Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
Michela Serresi, Gaetano Gargiulo, Natalie Proost, et al.
Cell Death and Differentiation
|
July 25, 2021
Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis
Lahiru Gangoda, Robyn L Schenk, Sarah A Best, et al.
Cell Metabolism
|
March 13, 2018
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Sarah A Best, David P De Souza, Ariena Kersbergen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2025
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis
Stephanie R Hyslop, Jason Corbin, Pradnya Gangatirkar, et al.
Nature Communications
|
September 15, 2019
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
Sarah A Best, Sheryl Ding, Ariena Kersbergen, et al.
Nature Cell Biology
|
December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Marie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
The EMBO Journal
|
December 2, 2006
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3
Kate D Sutherland, François Vaillant, Warren S Alexander, et al.
Oncogene
|
June 15, 2020
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
Stephanie R Hyslop, Marliese Alexander, Alesha A Thai, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Developmental Biology
|
September 9, 2018
Lung morphogenesis is orchestrated through Grainyhead-like 2 (Grhl2) transcriptional programs
Ariena Kersbergen, Sarah A Best, Sebastian Dworkin, et al.
Cancer Cell
|
January 15, 2016
Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
Michela Serresi, Gaetano Gargiulo, Natalie Proost, et al.
Cell Death and Differentiation
|
July 25, 2021
Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis
Lahiru Gangoda, Robyn L Schenk, Sarah A Best, et al.
Cell Metabolism
|
March 13, 2018
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Sarah A Best, David P De Souza, Ariena Kersbergen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2025
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis
Stephanie R Hyslop, Jason Corbin, Pradnya Gangatirkar, et al.
Nature Communications
|
September 15, 2019
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
Sarah A Best, Sheryl Ding, Ariena Kersbergen, et al.
Nature Cell Biology
|
December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Marie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
The EMBO Journal
|
December 2, 2006
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3
Kate D Sutherland, François Vaillant, Warren S Alexander, et al.
Oncogene
|
June 15, 2020
Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
Stephanie R Hyslop, Marliese Alexander, Alesha A Thai, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Page
of 6